Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50 to 75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 Study Rationale, Design, and Methods
2014 ◽
Vol 20
(10)
◽
pp. 1566-1572
◽
2020 ◽
Vol 26
(3)
◽
pp. S62-S63
2017 ◽
Vol 23
(8)
◽
pp. 1320-1326
◽
2021 ◽
Vol 27
(3)
◽
pp. S2-S3
2013 ◽
Vol 19
(2)
◽
pp. S312
2018 ◽
Vol 97
(10)
◽
pp. 1975-1985
◽
2018 ◽
Vol 24
(2)
◽
pp. 228-241
◽
2012 ◽
Vol 54
(8)
◽
pp. 1713-1718
◽
2008 ◽
Vol 14
(2)
◽
pp. 53-54